Trimethoprim-sulphamethoxazole treatment in staphylococcal endocarditis and gram-negative septicemia.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001431:Bacteriological Techniques; D004338:Drug Combinations; D004562:Electrocardiography; D004696:Endocarditis / Q000382:microbiology; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole